A detailed history of Granahan Investment Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Granahan Investment Management, LLC holds 131,146 shares of BPMC stock, worth $11.8 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
131,146
Previous 139,732 6.14%
Holding current value
$11.8 Million
Previous $15.1 Million 19.49%
% of portfolio
0.51%
Previous 0.63%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$84.1 - $120.5 $722,082 - $1.03 Million
-8,586 Reduced 6.14%
131,146 $12.1 Million
Q2 2024

Aug 14, 2024

SELL
$85.18 - $108.78 $3.37 Million - $4.31 Million
-39,585 Reduced 22.08%
139,732 $15.1 Million
Q1 2024

May 15, 2024

BUY
$73.17 - $99.79 $864,137 - $1.18 Million
11,810 Added 7.05%
179,317 $17 Million
Q4 2023

Feb 14, 2024

SELL
$43.96 - $92.84 $2.71 Million - $5.73 Million
-61,740 Reduced 26.93%
167,507 $15.5 Million
Q3 2023

Nov 14, 2023

BUY
$46.9 - $66.0 $2.1 Million - $2.95 Million
44,744 Added 24.25%
229,247 $11.5 Million
Q2 2023

Aug 14, 2023

SELL
$42.2 - $66.37 $2.01 Million - $3.17 Million
-47,716 Reduced 20.55%
184,503 $11.7 Million
Q1 2023

May 15, 2023

BUY
$37.97 - $50.0 $281,167 - $370,250
7,405 Added 3.29%
232,219 $10.4 Million
Q4 2022

Feb 14, 2023

BUY
$41.06 - $66.48 $3.31 Million - $5.36 Million
80,637 Added 55.93%
224,814 $9.85 Million
Q3 2022

Nov 14, 2022

BUY
$49.93 - $77.7 $2.02 Million - $3.15 Million
40,531 Added 39.11%
144,177 $9.5 Million
Q2 2022

Aug 15, 2022

SELL
$45.23 - $70.15 $2.4 Million - $3.72 Million
-53,000 Reduced 33.83%
103,646 $5.24 Million
Q1 2022

May 16, 2022

BUY
$54.1 - $110.08 $5.73 Million - $11.7 Million
105,921 Added 208.81%
156,646 $10 Million
Q4 2021

Feb 14, 2022

SELL
$94.25 - $115.99 $195,286 - $240,331
-2,072 Reduced 3.92%
50,725 $5.43 Million
Q3 2021

Nov 15, 2021

SELL
$80.98 - $109.47 $767,771 - $1.04 Million
-9,481 Reduced 15.22%
52,797 $5.43 Million
Q2 2021

Aug 16, 2021

BUY
$82.78 - $101.0 $279,051 - $340,471
3,371 Added 5.72%
62,278 $5.48 Million
Q1 2021

May 17, 2021

SELL
$90.71 - $108.28 $3.53 Million - $4.21 Million
-38,875 Reduced 39.76%
58,907 $5.73 Million
Q4 2020

Feb 12, 2021

SELL
$92.08 - $124.48 $2.83 Million - $3.83 Million
-30,777 Reduced 23.94%
97,782 $11 Million
Q3 2020

Nov 12, 2020

BUY
$66.45 - $92.7 $1.19 Million - $1.65 Million
17,833 Added 16.11%
128,559 $11.9 Million
Q2 2020

Aug 14, 2020

BUY
$57.09 - $79.27 $6.32 Million - $8.78 Million
110,726 New
110,726 $8.64 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.39B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.